
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
JEF | NYSE | USD | Real-time | |
LN3 | Frankfurt | EUR | Delayed | |
LN3 | TradeGate | EUR | Delayed |
Jefferies (NYSE:JEF) analyst Maury Raycroft reiterated a Buy rating on Aurinia Pharmaceuticals (NASDAQ:AUPH) on Wednesday, setting a price target of $35, which is approximately 94.34% above the...
Jefferies (NYSE:JEF) analyst Peter Welford maintained a Buy rating on Sanofi (NASDAQ:SNY) on Wednesday, setting a price target of EUR120, which is approximately 44.56% above the present share price...
Jefferies (NYSE:JEF) analyst Robert Dickerson maintained a Hold rating on Campbell Soup Company (NYSE:CPB) on Tuesday, setting a price target of $45, which is approximately 3.07% above the present...
By Aaron Saldanha and Matt Scuffham NEW YORK (Reuters) - JPMorgan Chase & Co (NYSE:JPM) instructed unvaccinated staff in Manhattan to work from home starting Tuesday, a further sign that banks and...
(Reuters) - Apple Inc (NASDAQ:AAPL) will require all customers and employees to wear masks at its U.S. retail stores, the iPhone maker said on Tuesday, as COVID-19 cases surge in the country. Last...
By Danilo Masoni and Joice Alves (Reuters) - The "Buy UK" equity trade that many viewed as a no-brainer at the start of 2021 looks like it has backfired, with British equities suffering record...
Jefferies (NYSE:JEF) analyst Maury Raycroft reiterated a Buy rating on Aurinia Pharmaceuticals (NASDAQ:AUPH) on Friday, setting a price target of $36, which is approximately 80.90% above the present...
Investors are optimistic about the forthcoming Federal Reserve meeting. So, we think it could be wise to bet on quality stocks QUALCOMM Incorporated (NASDAQ:QCOM), GMS Inc . (NYSE:GMS), Axcelis...
Jefferies (NYSE:JEF) analyst Corey Tarlowe maintained a Buy rating on Torrid Holdings on Tuesday, setting a price target of $25, which is approximately 118.91% above the present share price of...
Jefferies (NYSE:JEF) analyst Eun Yang maintained a Buy rating on Keros Therapeutics on Monday, setting a price target of $75, which is approximately 52.91% above the present share price of...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review